Flavonoids isolated from the South African weed Chromolaena odorata (Asteraceae) have pharmacological activity against uropathogens.

Background: Urinary tract infections (UTIs) caused by opportunistic pathogens are among the leading health challenges globally. Most available treatment options are failing as a result of antibiotic resistance and adverse effects. Natural sources such as plants may serve as promising alternatives. M...

Descripción completa

Detalles Bibliográficos
Publicado en:BMC Complementary Medicine & Therapies Vol. 20; no. 1; pp. 1 - 16
Autores principales: Omokhua-Uyi, Aitebiremen G., Abdalla, Muna A., Leonard, Carmen M., Aro, Abimbola, Uyi, Osariyekemwen O., Van Staden, Johannes, McGaw, Lyndy J.
Formato: equations & formulas pictorial research tables/charts Journal Article
Publicado: BioMed Central 7/23/2020
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=144731133&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 144731133
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        26627671
        MFH8
      jtl: BMC Complementary Medicine & Therapies
      issn: 26627671
      maglogo: N
    pubinfo:
      dt: 7/23/2020
      vid: 20
      iid: 1
      pid: 24147
      pub: BioMed Central
    artinfo:
      ui:
        144731133
        144731133
        144731133
        10.1186/s12906-020-03024-0
        144731133
      ppf: 1
      ppct: 15
      formats:
      tig:
        atl: Flavonoids isolated from the South African weed Chromolaena odorata (Asteraceae) have pharmacological activity against uropathogens.
      aug:
        au:
          Omokhua-Uyi, Aitebiremen G.
          Abdalla, Muna A.
          Leonard, Carmen M.
          Aro, Abimbola
          Uyi, Osariyekemwen O.
          Van Staden, Johannes
          McGaw, Lyndy J.
        affil: Phytomedicine Programme, Department of Paraclinical Sciences, University of Pretoria, Private Bag X04, 0110, Onderstepoort, South Africa
      sug:
        subj:
          Flavonoids Pharmacodynamics
          Plant Extracts Pharmacodynamics
          Urinary Tract Drug Effects
          Urinary Tract Infections Drug Therapy
          Human
          Animal Studies
          Primates
          South Africa
          Chromatography Methods
          Colorimetry
          Staphylococcus Aureus Drug Effects
          Escherichia Coli Drug Effects
          Klebsiella Drug Effects
          Aspergillus Drug Effects
          Cryptococcus Drug Effects
          Biofilms Drug Effects
          Kidney Drug Effects
          Liver Drug Effects
          Colon Drug Effects
          Flavanones Pharmacodynamics
          Ciprofloxacin Administration and Dosage
          Amphotericin B Administration and Dosage
          Gentamicins Administration and Dosage
          Molecular Structure
      ab: Background: Urinary tract infections (UTIs) caused by opportunistic pathogens are among the leading health challenges globally. Most available treatment options are failing as a result of antibiotic resistance and adverse effects. Natural sources such as plants may serve as promising alternatives. Methods: Compounds were isolated from the South African weed Chromolaena odorata through column chromatography. Purified compounds were tested for antimicrobial activity using the p-iodonitrotetrazolium chloride (INT) colorimetric method, against uropathogenic Escherichia coli, Staphylococcus aureus, Klebsiella pneumoniae, Aspergillus fumigatus and Cryptococcus neoformans. Anti-biofilm, anti-adhesion and metabolic inhibition activities were investigated against selected strains. Safety of the compounds was determined against Vero monkey kidney, C3A human liver and colon (Caco2) cells. Results: Four compounds identified as pectolinaringenin (1), (±)-4′,5,7-trimethoxy flavanone (2), 5-hydroxy-3,7,4′-trimethoxyflavone (3) and 3,5,7-trihydroxy-4′-methoxyflavone) (4) were isolated. Minimum inhibitory concentration (MIC) varied between 0.016 and 0.25 mg/mL. Compounds 2 and 3 showed promising antimicrobial activity against E. coli, S. aureus, K. pneumoniae, A. fumigatus and C. neoformans with MIC between 0.016 and 0.125 mg/mL, comparable to gentamicin, ciprofloxacin and amphotericin B used as positive controls. Compounds 2 and 3 showed good anti-biofilm and metabolic inhibition activities against E. coli and S. aureus but weak anti-adhesion activity against the organisms. Low toxicity with selectivity indexes between 1 and 12.625 were recorded with the compounds, indicating that the compounds were rather toxic to the microbial strains and not to the human and animal cells. Conclusion: Pharmacological activities displayed by compounds 2 and 3 isolated from C. odorata and low toxicity recorded credits it as a potential lead for the development of useful prophylactic treatments and anti-infective drugs against UTIs. Although known compounds, this is the first time these compounds have been isolated from the South African weed C. odorata and tested for antimicrobial, anti-biofilm, metabolic inhibition and anti-adhesion activities.
      pubtype: Academic Journal
      doctype:
        equations & formulas
        pictorial
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N